Convergent Capital Partners IV, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest, 79930 [2022-28212]

Download as PDF 79930 Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices received will be posted without change. Persons submitting comments are cautioned that we do not redact or edit personal identifying information from comment submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–MRX–2022–29 and should be submitted on or before January 18, 2023. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.56 Sherry R. Haywood, Assistant Secretary. [FR Doc. 2022–28199 Filed 12–27–22; 8:45 am] BILLING CODE 8011–01–P SMALL BUSINESS ADMINISTRATION [License No. 05/05–0344] ddrumheller on DSK6VXHR33PROD with NOTICES Convergent Capital Partners IV, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest Notice is hereby given that Convergent Capital Partners IV, LP, 9855 West 78th Street, Suite 320, Eden Prairie, MN 55344, a Federal Licensee under the Small Business Investment Act of 1958, as amended (‘‘the Act’’), in connection with the financing of a small concern, has sought an exemption under section 312 of the Act and 13 CFR 107.730, Financings which Constitute Conflicts of Interest of the Code of Federal Regulations. Convergent Capital Partners IV, LP, is seeking a written exemption from SBA for a proposed financing to Optimum Healthcare IT, LLC, 1300 Marsh Landing Parkway, Jacksonville Beach, FL 32250. The financing is brought within the purview of 13 CFR 107.730(a)(4) of the Code of Federal Regulations because proceeds from the financing will discharge the obligation of Convergent Capital Partners III, LP, an Associate by virtue of Common Control as defined at 13 CFR 107.50. Notice is hereby given that any interested person may submit written comments on this transaction within fifteen days of the date of this publication to the Associate Administrator, Office of Investment and Innovation, U.S. Small Business 56 17 Administration, 409 Third Street SW, Washington, DC 20416. Administration, 409 Third Street SW, Washington, DC 20416. Bailey DeVries, Associate Administrator, Office of Investment and Innovation, U.S. Small Business Administration. Bailey DeVries, Associate Administrator, Office of Investment and Innovation, U.S. Small Business Administration. [FR Doc. 2022–28212 Filed 12–27–22; 8:45 am] [FR Doc. 2022–28213 Filed 12–27–22; 8:45 am] BILLING CODE P BILLING CODE P SMALL BUSINESS ADMINISTRATION [Public Notice: 11952] [License No. 04/04–0349] New Canaan Funding Mezzanine VII SBIC, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest Notice is hereby given that New Canaan Funding Mezzanine VII SBIC, LP, 305 Fifth Avenue South, Suite 204 Naples, FL 34102, a Federal Licensee under the Small Business Investment Act of 1958, as amended (‘‘the Act’’), in connection with the financing of a small concerns, has sought an exemption under section 312 of the Act and 13 CFR 107.730, Financings which Constitute Conflicts of Interest of the Code of Federal Regulations. New Canaan Funding Mezzanine VII SBIC, LP is proposing to provide financing to Safemark Inc., 200 W. Sand Lake Rd., Suite 800, Orlando, FL to support the company’s growth. The proposed transaction is brought within the purview of 13 CFR 107.730 of the Code of Federal Regulations because New Canaan Funding Mezzanine V SBIC, LP and New Canaan Funding Mezzanine V, LP, Associates of New Canaan Funding Mezzanine VII SBIC, LP, by virtue of Common Control as defined at 13 CFR 107.50, hold investments in Safemark, Inc. which will be discharged. In addition, New Canaan Funding Mezzanine VII SBIC, LP and its Associates did not previously invest in Safemark, Inc. at the same time and on the same terms and conditions as the proposed financing to Safemark, Inc. Therefore, the proposed transaction is considered self-deal pursuant to 13 CFR 107.730 and requires a regulatory exemption. Notice is hereby given that any interested person may submit written comments on the transaction within fifteen days of the date of this publication to Associate Administrator for Investment, U.S. Small Business CFR 200.30–3(a)(12). VerDate Sep<11>2014 18:26 Dec 27, 2022 Jkt 259001 DEPARTMENT OF STATE PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 U.S. Department of State Advisory Committee on Private International Law: Public Meeting on the Final Report of the Experts Group on Parentage/Surrogacy Project of the Hague Conference on Private International Law (HCCH). The Department of State’s Advisory Committee on Private International Law (ACPIL) will hold a virtual meeting to discuss the Hague Experts Group Final Report on Parentage/Surrogacy Project on Wednesday February 1, 2023. The meeting will be held in WebEx. The program is scheduled to run from 1 p.m. to 4 p.m. The meeting will discuss the Final Report of the Experts’ Group regarding the feasibility of one or more private international law instruments on legal parentage. The Final Report has been made available on the HCCH website at https://assets.hcch.net/docs/6d8eeb81ef67-4b21-be42-f7261d0cfa52.pdf. The Report will be considered by the Council on General Affairs and Policy (CGAP) in March 2023, at which CGAP is expected to decide on whether future work on the project should be pursued. This Report presents the HCCH Experts’ Group on Parentage/Surrogacy analysis and main conclusions on the feasibility of the core aspects of possible options for two separate binding legal instruments on legal parentage: one on legal parentage in general, and another on legal parentage established as a result of an international surrogacy arrangement (ISA) specifically. The purpose of the public meeting is to obtain the views of concerned stakeholders on the matters presented in the Report. Members of the public may attend this virtual session and will be permitted to participate in the discussion. Virtual attendance is limited to 100 persons, so each member of the public that wishes to attend this session must provide: Name, contact information, and affiliation to pil@ state.gov, not later than January 23, 2023. When you register, please indicate whether you require captioning. The E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Page 79930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28212]


=======================================================================
-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 05/05-0344]


Convergent Capital Partners IV, LP; Notice Seeking Exemption 
Under Section 312 of the Small Business Investment Act, Conflicts of 
Interest

    Notice is hereby given that Convergent Capital Partners IV, LP, 
9855 West 78th Street, Suite 320, Eden Prairie, MN 55344, a Federal 
Licensee under the Small Business Investment Act of 1958, as amended 
(``the Act''), in connection with the financing of a small concern, has 
sought an exemption under section 312 of the Act and 13 CFR 107.730, 
Financings which Constitute Conflicts of Interest of the Code of 
Federal Regulations. Convergent Capital Partners IV, LP, is seeking a 
written exemption from SBA for a proposed financing to Optimum 
Healthcare IT, LLC, 1300 Marsh Landing Parkway, Jacksonville Beach, FL 
32250.
    The financing is brought within the purview of 13 CFR 107.730(a)(4) 
of the Code of Federal Regulations because proceeds from the financing 
will discharge the obligation of Convergent Capital Partners III, LP, 
an Associate by virtue of Common Control as defined at 13 CFR 107.50.
    Notice is hereby given that any interested person may submit 
written comments on this transaction within fifteen days of the date of 
this publication to the Associate Administrator, Office of Investment 
and Innovation, U.S. Small Business Administration, 409 Third Street 
SW, Washington, DC 20416.

Bailey DeVries,
Associate Administrator, Office of Investment and Innovation, U.S. 
Small Business Administration.
[FR Doc. 2022-28212 Filed 12-27-22; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.